• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    This Biotechnology Stock Tumbled 37%; Here Are 70 Biggest Movers From Yesterday

    8/19/22 3:54:34 AM ET
    $ALLR
    $AURA
    $AXDX
    $BBBY
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Get the next $ALLR alert in real time by email

    Gainers

    • Bright Minds Biosciences Inc. (NASDAQ:DRUG) shares climbed 135.9% to close at $2.17 on Thursday.
    • Plus Therapeutics, Inc. (NASDAQ:PSTV) shares climbed 53.9% to close at $0.8480
    • after the company announced it was awarded $17.6 million Product Development Research grant by the Cancer Prevention and Research Institute of Texas to fund radiotherapeutic, Rhenium-186 NanoLiposome.
    • Neptune Wellness Solutions Inc. (NASDAQ:NEPT) rose 49.6% to close at $2.02 after the company announced sales have outperformed Walmart's expectations.
    • Lizhi Inc. (NASDAQ:LIZI) gained 43.1% to settle at $1.76.
    • Endo International plc (NASDAQ:ENDP) jumped 42.9% to settle at $0.4057 after dipping 23% on Wednesday. Endo International filed for bankruptcy after reaching a $6 billion deal with some of its creditors as the company sought to settle opioid-related lawsuits.
    • Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) shares gained 36.2% to settle at $1.02 amid mention of the stock on Discord. Mind Medicine recently posted a Q2 loss of $0.04 per share.
    • Indonesia Energy Corporation Limited (NASDAQ:INDO) surged 33.3% to close at $7.80.
    • Wolfspeed, Inc. (NYSE:WOLF) shares surged 31.8% to settle at $112.91 after the company reported better-than-expected Q4 EPS and sales results. Additionally, multiple firms raised their price target on the stock.
    • Genius Group Limited (NYSE:GNS) jumped 28.2% to close at $8.18.
    • Weber Inc. (NYSE:WEBR) gained 27.2% to close at $10.00.
    • LightPath Technologies, Inc. (NASDAQ:LPTH) climbed 26.8% to close at $1.80.
    • Golden Sun Education Group Limited (NASDAQ:GSUN) gained 25% to settle at $66.15.
    • Larimar Therapeutics, Inc. (NASDAQ:LRMR) surged 24.6% to close at $2.89. Larimar Therapeutics recently announced it received meeting minutes from the FDA following a recent Type C Meeting and plans to submit a complete response to the CTI-1601 clinical hold in Q3.
    • Horizon Global Corporation (NYSE:HZN) gained 24.5% to close at $2.39. Horizon Global recently posted a Q2 loss of $0.80 per share.
    • Edible Garden AG Incorporated (NASDAQ:EDBL) rose 22.9% to settle at $1.34. Edible Garden recently posted a Q2 loss of $0.68 per share.
    • Grove Collaborative Holdings, Inc. (NYSE:GROV) jumped 22.9% to close at $6.98.
    • Allarity Therapeutics, Inc. (NASDAQ:ALLR) gained 22.6% to close at $1.52.
    • Cyngn Inc. (NASDAQ:CYN) surged 21.5% to settle at $1.47. Cyngn recently posted a Q2 loss of $0.15 per share.
    • Seelos Therapeutics, Inc. (NASDAQ:SEEL) rose 21.5% to close at $1.13 as volume increases in psychedelic stocks.
    • Curis, Inc. (NASDAQ:CRIS) rose 20% to close at $1.26 after the company announced the U.S. FDA has lifted the partial clinical hold on the TakeAim Lymphoma Phase 1/2 study of emavusertib.
    • Milestone Pharmaceuticals Inc. (NASDAQ:MIST) gained 19.4% to close at $7.76. Milestone Pharmaceuticals recently posted a Q2 loss of $0.39 per share.
    • Mannatech, Incorporated (NASDAQ:MTEX) gained 17.1% to close at $23.50. Mannatech recently reported a second-quarter FY22 sales decline of 17.7% year-on-year, to $35 million.
    • Brooge Energy Limited (NASDAQ:BROG) surged 17% to settle at $8.45.
    • Canadian Solar Inc. (NASDAQ:CSIQ) jumped 15.2% to close at $45.19 after the company reported better-than-expected Q2 results and raised Q3 and FY22 sales guidance above estimates.
    • Mammoth Energy Services, Inc. (NASDAQ:TUSK) jumped 13.7% to close at $4.41.
    • Grindrod Shipping Holdings Ltd. (NASDAQ:GRIN) rose 13.2% to close at $21.70. Grindrod Shipping reported a second-quarter revenue increase of 47.1% year-over-year to $161.58 million.
    • Tellurian Inc. (NASDAQ:TELL) gained 13% to close at $4.68.
    • EQRx, Inc. (NASDAQ:EQRX) gained 12.6% to close at $5.43.
    • Silence Therapeutics plc (NASDAQ:SLN) gained 11.9% to close at $9.62.
    • Peabody Energy Corporation (NYSE:BTU) rose 11.5% to close at $25.90.
    • EnLink Midstream, LLC (NYSE:ENLC) climbed 9.9% to close at $10.81. The company recently posted upbeat quarterly sales.
    • Codiak BioSciences, Inc. (NASDAQ:CDAK) shares gained 9.1% to close at $2.52. Codiak BioSciences recently posted a Q2 loss of $0.30 per share.
    • Alpha Tau Medical Ltd. (NASDAQ:DRTS) gained 8% to close at $9.89.
    • Helmerich & Payne, Inc. (NYSE:HP) gained 8% to settle at $44.00.
    • ON Semiconductor Corporation (NASDAQ:ON) rose 7.3% to close at $73.25 in sympathy with Wolfspeed, which reported better-than-expected Q4 EPS and sales results. Both companies are involved in making products in the auto sector.
    • BJ's Wholesale Club Holdings, Inc. (NYSE:BJ) climbed 7.2% to close at $74.09 after the company reported better-than-expected Q2 EPS and sales results and raised FY22 EPS guidance above estimates.
    • Keysight Technologies, Inc. (NYSE:KEYS) rose 6.2% to close at $179.70 as the company reported upbeat earnings for its third quarter and issued a strong forecast for the fourth quarter.
    • Cisco Systems, Inc. (NASDAQ:CSCO) rose 5.8% to settle at $49.37 after the company reported better-than-expected results for its fourth quarter and issued strong guidance.

     

    Losers

    • Blue Water Vaccines, Inc. (NASDAQ:BWV) shares fell 43.9% to close at $4.2850 on possible profit taking after the stock surged on Wednesday.
    • Unity Biotechnology, Inc. (NASDAQ:UBX) shares fell 37.1 to close at $0.6101 after the company reported pricing of upsized underwritten public offering.
    • TDH Holdings, Inc. (NASDAQ:PETZ) shares dipped 30.1% to settle at $2.98 after jumping 38% on Wednesday.
    • WeTrade Group, Inc. (NASDAQ:WETG) fell 28.5% to close at $5.12. WeTrade Group said, 'WeTrade and Zhixun are ready to launch an in-depth cooperative sales promotion of Zhixun's disinfectant.'
    • Accelerate Diagnostics, Inc. (NASDAQ:AXDX) fell 27.2% to close at $2.49 after the company announced the proposed public offering of its common stock.
    • ECMOHO Limited (NASDAQ:MOHO) dipped 26.1% to close at $0.1650.
    • America's Car-Mart, Inc. (NASDAQ:CRMT) declined 22.7% to close at $92.38 after the company reported worse-than-expected Q1 EPS results.
    • Veru Inc. (NASDAQ:VERU) fell 21.5% to close at $18.67.
    • GreenBox POS (NASDAQ:GBOX) dropped 21.1% to settle at $1.42.
    • LumiraDx Limited (NASDAQ:LMDX) dipped 20% to settle at $1.20 after the company reported worse-than-expected Q2 adjusted EPS and sales results.
    • Bed Bath & Beyond Inc. (NASDAQ:BBBY) fell 19.6% to close at $18.55 following a Form 144 filing by RC Ventures, which suggested the firm proposed to sell 7.78 million common shares and certain call options. Additionally, Wedbush downgraded the stock to Underperform.
    • Kirkland's, Inc. (NASDAQ:KIRK) fell 18.6% to close at $5.21. The company is scheduled to report Q2 results on August 30, 2022.
    • Rite Aid Corporation (NYSE:RAD) dipped 18.5% to close at $8.57.
    • Nova LifeStyle, Inc. (NASDAQ:NVFY) dropped 18.1% to close at $0.9013.
    • Ensysce Biosciences, Inc. (NASDAQ:ENSC) fell 17.4% to close at $0.45. Zacks Small-Cap Research recently published a note on the stock with a $12 valuation.
    • Exscientia plc (NASDAQ:EXAI) fell 16.8% to close at $9.55 after the company reported worse-than-expected Q2 EPS results.
    • Party City Holdco Inc. (NYSE:PRTY) dropped 16.1% to settle at $1.98.
    • Cadiz Inc. (NASDAQ:CDZI) fell 16% to close at $4.26.
    • Eargo, Inc. (NASDAQ:EAR) fell 15.7% to close at $2.64 on possible profit taking after the stock surged on Wednesday.
    • Root, Inc. (NASDAQ:ROOT) fell 15.5% to close at $17.13.
    • Calliditas Therapeutics AB (publ) (NASDAQ:CALT) dropped 15.1% to close at $18.00
    • after the company reported worse-than-expected Q2 sales results.
    • Puhui Wealth Investment Management Co., Ltd. (NASDAQ:PHCF) declined 15% to close at $0.85.
    • CI&T Inc (NYSE:CINT) fell 14.8% to settle at $11.45 after Q2 results.
    • bluebird bio, Inc. (NASDAQ:BLUE) shares fell 14.3% to close at $5.81 The FDA has approved Bluebird bio’s Zynteglo (betibeglogene autotemcel), also known as beti-cel, a one-time gene therapy custom-designed for beta‑thalassemia.
    • Aura Biosciences, Inc. (NASDAQ:AURA) fell 13.5% to settle at $17.59. Aura Biosciences recently reported cash, cash on hand as of June 30, 2022 of $122.1 million.
    • Embark Technology, Inc. (NASDAQ:EMBK) dropped 13.4% to close at $11.42.
    • Lottery.com Inc. (NASDAQ:LTRY) fell 13.3% to close at $0.3641.
    • Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC) fell 12.9% to close at $1.75. Cyclacel Pharmaceuticals recently said Q2 EPS results were up year over year.
    • VBI Vaccines Inc. (NASDAQ:VBIV) fell 11.4% to close at $1.09.
    • Soluna Holdings, Inc. (NASDAQ:SLNH) fell 11% to close at $3.48.
    • Hut 8 Mining Corp. (NASDAQ:HUT) fell 10% to close at $2.69 after the company launched at-the-market equity program of up to $200 million.
    • Big 5 Sporting Goods Corporation (NASDAQ:BGFV) fell 8.3% to settle at $8.57.
    • Walgreens Boots Alliance, Inc. (NASDAQ:WBA) dropped 5.3% to close at $38.24. It was reported on Wednesday the company and other pharmacy operators will be required to pay $650.6 million to two Ohio counties in an opioid case.
    Get the next $ALLR alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ALLR
    $AURA
    $AXDX
    $BBBY

    CompanyDatePrice TargetRatingAnalyst
    Keysight Technologies Inc.
    $KEYS
    2/24/2026$340.00Neutral → Buy
    BofA Securities
    Cisco Systems Inc.
    $CSCO
    2/18/2026Buy → Hold
    Erste Group
    ON Semiconductor Corporation
    $ON
    2/12/2026$75.00Equal Weight
    Barclays
    ON Semiconductor Corporation
    $ON
    2/10/2026Buy → Hold
    The Benchmark Company
    Helmerich & Payne Inc.
    $HP
    2/9/2026$35.00 → $38.00Hold
    TD Cowen
    PLUS THERAPEUTICS Inc.
    $PSTV
    2/3/2026$2.00Buy
    Lake Street
    CADIZ Inc.
    $CDZI
    2/2/2026$10.00Buy
    Maxim Group
    Hut 8 Corp.
    $HUT
    2/2/2026$80.00Buy
    H.C. Wainwright
    More analyst ratings

    $ALLR
    $AURA
    $AXDX
    $BBBY
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    President and CEO Kras James E. bought $2,050 worth of shares (3,700 units at $0.55), increasing direct ownership by 102% to 7,317 units (SEC Form 4)

    4 - Edible Garden AG Inc (0001809750) (Issuer)

    1/5/26 8:51:35 AM ET
    $EDBL
    Farming/Seeds/Milling
    Consumer Staples

    Director Amron Arthur H bought $18,900 worth of shares (10,000 units at $1.89), increasing direct ownership by 21% to 57,135 units (SEC Form 4)

    4 - MAMMOTH ENERGY SERVICES, INC. (0001679268) (Issuer)

    12/15/25 5:04:40 PM ET
    $TUSK
    Oilfield Services/Equipment
    Energy

    Chief Financial Officer Collins Jonathan M. bought $4,978 worth of shares (197 units at $25.27), increasing direct ownership by 3% to 6,444 units (SEC Form 4)

    4 - AMERICAS CARMART INC (0000799850) (Issuer)

    12/12/25 9:25:57 PM ET
    $CRMT
    Retail-Auto Dealers and Gas Stations
    Consumer Discretionary

    $ALLR
    $AURA
    $AXDX
    $BBBY
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    December 8, 2023 - FDA Approves First Gene Therapies to Treat Patients with Sickle Cell Disease

    For Immediate Release: December 08, 2023 Today, the U.S. Food and Drug Administration approved two milestone treatments, Casgevy and Lyfgenia, representing the first cell-based gene therapies for the treatment of sickle cell disease (SCD) in patients 12 years and older. Additionally, one of these therapies, Casgevy, is the first FDA-approved treatment to utilize a type of novel genome editing technology, signali

    12/8/23 11:12:21 AM ET
    $BLUE
    $VRTX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Biotechnology: Pharmaceutical Preparations

    September 12, 2023 - FDA Issues Warning Letters to Firms Marketing Unapproved Eye Products

    For Immediate Release: September 12, 2023 The U.S. Food and Drug Administration has issued warning letters to eight companies for manufacturing or marketing unapproved ophthalmic drug products in violation of federal law. These warning letters are part of the agency’s ongoing effort to protect Americans from potentially harmful ophthalmic products. Eye products addressed in the eight warning letters are illegal

    9/12/23 10:44:21 AM ET
    $WBA
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    August 17, 2022 - FDA Approves First Cell-Based Gene Therapy to Treat Adult and Pediatric Patients with Beta-thalassemia Who Require Regular Blood Transfusions

    For Immediate Release: August 17, 2022 Today, the U.S. Food and Drug Administration approved Zynteglo (betibeglogene autotemcel), the first cell-based gene therapy for the treatment of adult and pediatric patients with beta-thalassemia who require regular red blood cell transfusions.  “Today’s approval is an important advance in the treatment of beta-thalassemia, particularly in individuals who require ongoing

    8/17/22 2:12:27 PM ET
    $BLUE
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $ALLR
    $AURA
    $AXDX
    $BBBY
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director North Run Strategic Opportunities Fund I, Lp sold $3,655,121 worth of shares (300,092 units at $12.18) (SEC Form 4)

    4 - LIGHTPATH TECHNOLOGIES INC (0000889971) (Issuer)

    2/27/26 4:44:08 PM ET
    $LPTH
    Semiconductors
    Technology

    SEC Form 4 filed by Chief Financial Officer Sims Andrew John Hugh Macintyre

    4 - PLUS THERAPEUTICS, INC. (0001095981) (Issuer)

    2/27/26 4:08:43 PM ET
    $PSTV
    Medical/Dental Instruments
    Health Care

    SEC Form 4 filed by Chief Executive Officer Hedrick Marc H

    4 - PLUS THERAPEUTICS, INC. (0001095981) (Issuer)

    2/27/26 4:07:51 PM ET
    $PSTV
    Medical/Dental Instruments
    Health Care

    $ALLR
    $AURA
    $AXDX
    $BBBY
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Keysight upgraded by BofA Securities with a new price target

    BofA Securities upgraded Keysight from Neutral to Buy and set a new price target of $340.00

    2/24/26 11:27:19 AM ET
    $KEYS
    Industrial Machinery/Components
    Industrials

    Cisco downgraded by Erste Group

    Erste Group downgraded Cisco from Buy to Hold

    2/18/26 9:41:39 AM ET
    $CSCO
    Computer Communications Equipment
    Telecommunications

    Barclays initiated coverage on onsemi with a new price target

    Barclays initiated coverage of onsemi with a rating of Equal Weight and set a new price target of $75.00

    2/12/26 9:42:14 AM ET
    $ON
    Semiconductors
    Technology

    $ALLR
    $AURA
    $AXDX
    $BBBY
    SEC Filings

    View All

    LightPath Technologies Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - LIGHTPATH TECHNOLOGIES INC (0000889971) (Filer)

    2/27/26 4:55:45 PM ET
    $LPTH
    Semiconductors
    Technology

    Ensysce Biosciences Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

    8-K - Ensysce Biosciences, Inc. (0001716947) (Filer)

    2/27/26 4:30:54 PM ET
    $ENSC
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 6-K filed by Canadian Solar Inc.

    6-K - Canadian Solar Inc. (0001375877) (Filer)

    2/27/26 6:37:58 AM ET
    $CSIQ
    Semiconductors
    Technology

    $ALLR
    $AURA
    $AXDX
    $BBBY
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Keysight and MediaTek Advance AI‑Driven Uplink Optimization and Model Life Cycle Management for Radio Access Networks

    Working prototype shows how artificial intelligence-radio access network techniques can adapt to site conditions and improve uplink performance at scale Keysight Technologies, Inc. (NYSE:KEYS) and MediaTek announced a working prototype that advances AI‑driven uplink optimization and model life cycle management for next‑generation radio access networks (RAN). The prototype will be demonstrated at Mobile World Congress 2026 and shows how AI‑enabled, RAN-assisted intelligence can improve uplink performance in real time while remaining effective over time through practical model retraining and over‑the‑air (OTA) updates, helping operators and ecosystem partners accelerate the transition to ne

    2/27/26 4:15:00 PM ET
    $KEYS
    Industrial Machinery/Components
    Industrials

    Follow-Through Leaders: Production Ramps, AI Alliances, Balance Sheet Strength

    DENVER, Feb. 27, 2026 (GLOBE NEWSWIRE) -- Markets reward momentum and trends may sustain when execution follows headlines. Several companies are now moving beyond announcements and into operational validation, positioning themselves for potential continued follow-through. From biomaterials scale-up to enterprise AI deployment and disciplined capital allocation, these names are building narratives that extend beyond a single news cycle. Kraig Biocraft Laboratories: From Strategy to Scale Activity has accelerated at Kraig Biocraft Laboratories (OTCQB:KBLB) following confirmation that its 2026 production plan has officially transitioned from roadmap to execution. The company has moved bio

    2/27/26 9:45:46 AM ET
    $ENSC
    $PLTR
    $RXT
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Computer Software: Prepackaged Software
    Technology

    Edible Garden to Showcase Zero-Waste Inspired® Platform and Announce Major Nutrition Platform Expansion at Natural Products Expo West® 2026 in Anaheim, California, March 3–6

    BELVIDERE, NJ, Feb. 27, 2026 (GLOBE NEWSWIRE) -- Edible Garden AG Incorporated ("Edible Garden" or the "Company") (NASDAQ:EDBL, EDBLW)), a leader in controlled environment agriculture (CEA) and producer of locally grown, organic, and sustainable produce and products, today announced its participation in Natural Products Expo West® 2026, taking place at the Anaheim Convention Center in Anaheim, California from March 3–6, 2026. The Company will exhibit at Booth #N1546, where it will highlight the strength of its vertically integrated growth platform and announce a significant strategic initiative reflecting the next stage of its corporate development. Natural Products Expo West® 2026, produ

    2/27/26 8:02:00 AM ET
    $EDBL
    Farming/Seeds/Milling
    Consumer Staples

    $ALLR
    $AURA
    $AXDX
    $BBBY
    Financials

    Live finance-specific insights

    View All

    Root, Inc. Announces 2025 Fourth Quarter and Full Year Results

    COLUMBUS, Ohio, Feb. 25, 2026 (GLOBE NEWSWIRE) -- Root, Inc. (NASDAQ:ROOT), today announced financial results for the fourth quarter and full year ended December 31, 2025. Root's fourth quarter and full year financial results and management commentary can be found in the shareholder letter posted to the company's investor relations website. An updated version of the company's investor presentation will also be available. Both can be found on ir.joinroot.com. Root will host a conference call and earnings webcast to discuss the results and provide an update on company operations today, Wednesday, February 25, 2026 at 5:00 p.m. Eastern Time. To listen to the live audio webcast, please visit

    2/25/26 4:15:00 PM ET
    $ROOT
    Property-Casualty Insurers
    Finance

    Plus Therapeutics Announces New Category III CPT Code for Convection-Enhanced Delivery Used with REYOBIQ™

    HOUSTON, Feb. 25, 2026 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (NASDAQ:PSTV) (the "Company"), a healthcare company developing and commercializing precision diagnostics and radiopharmaceuticals for central nervous system (CNS) cancers, today announced the American Medical Association's (AMA) CPT® (Current Procedural Terminology) Editorial Panel approved a new Category III CPT code to track utilization of convection-enhanced delivery (CED) used in the administration of REYOBIQ for recurrent glioblastoma (rGBM) and pediatric brain cancer (PBC).   "The approved Category III CPT code for convection-enhanced delivery of REYOBIQ in recurrent glioblastoma and pediatric brain cancer – the most

    2/25/26 7:30:00 AM ET
    $PSTV
    Medical/Dental Instruments
    Health Care

    Hut 8 Reports Fourth Quarter and Full Year 2025 Results

    Power-first model delivers first AI infrastructure transaction and advances multi-gigawatt growth strategy8,500 MW1 development pipeline as of December 31, 2025 sets foundation for scalable, repeatable execution in 2026Earnings Release HighlightsCommercialized AI infrastructure at scale, signing a 15-year, 245 MW IT lease with Fluidstack at the River Bend campus, representing $7.0 billion in base-term contract value.Refined portfolio structure and streamlined capital allocation framework through the sale of a 310 MW portfolio of four natural gas-fired power plants, which closed in February 2026, and the launch and public listing of American Bitcoin Corp., a majority-owned Bitcoin accumulatio

    2/25/26 6:30:00 AM ET
    $GS
    $HUT
    $JPM
    Investment Bankers/Brokers/Service
    Finance
    Finance: Consumer Services
    Major Banks

    $ALLR
    $AURA
    $AXDX
    $BBBY
    Leadership Updates

    Live Leadership Updates

    View All

    Cyngn Adds Former Lyft Exec, Ran Makavy, to Board

    Mr. Makavy led growth at Lyft and later ran its core platform through the 2019 IPO. He also founded Snaptu, which was acquired by Facebook in 2011.MOUNTAIN VIEW, Calif., Feb. 25, 2026 /PRNewswire/ -- Cyngn (NASDAQ:CYN) today announced the appointment of Ran Makavy to its Board of Directors. He brings senior growth and platform leadership experience from Lyft and Facebook, where he helped scale large technology businesses through high-growth phases. At Lyft, Makavy built the growth team which was responsible for getting more drivers and riders to use Lyft and getting them to use

    2/25/26 7:05:00 AM ET
    $CYN
    EDP Services
    Technology

    Wolfspeed Strengthens Global Sales Leadership with Addition of Semiconductor Leader, Stefan Steyerl, as VP of Sales, EMEA

    Wolfspeed, Inc. (NYSE:WOLF), a global leader in silicon carbide technology and manufacturing, today announced the appointment of Stefan Steyerl as vice president of sales, EMEA. Effective March 1, 2026, Steyerl will develop and execute Wolfspeed's regional sales strategy, driving adoption of silicon carbide solutions across automotive, industrial, and energy markets as Wolfspeed accelerates the adoption of silicon carbide technology to expand its market footprint and deliver revenue growth across the region. Steyerl brings more than 25 years of experience in the semiconductor industry, with a proven track record of building high-performance teams and achieving revenue growth across global

    2/17/26 8:00:00 AM ET
    $WOLF
    Semiconductors
    Technology

    Milestone Pharmaceuticals Appoints David Sandoval as General Counsel and Chief Compliance Officer

    MONTREAL and CHARLOTTE, N.C., Feb. 10, 2026 (GLOBE NEWSWIRE) -- Milestone Pharmaceuticals Inc. (NASDAQ:MIST) today announced the appointment of David Sandoval as General Counsel and Chief Compliance Officer. Mr. Sandoval's appointment comes as Milestone launches CARDAMYST™ (etripamil) nasal spray, the first and only approved self-administered treatment for the conversion of acute symptomatic episodes of paroxysmal supraventricular tachycardia (PSVT) to sinus rhythm in adults. CARDAMYST was approved by the U.S. Food and Drug Administration (FDA) on December 12, 2025. He will serve as a member of Milestone's executive leadership team and will provide business-focused legal counsel across all

    2/10/26 8:00:00 AM ET
    $MIST
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ALLR
    $AURA
    $AXDX
    $BBBY
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by LightPath Technologies Inc.

    SC 13G/A - LIGHTPATH TECHNOLOGIES INC (0000889971) (Subject)

    12/13/24 3:18:07 PM ET
    $LPTH
    Semiconductors
    Technology

    Amendment: SEC Form SC 13G/A filed by CADIZ Inc.

    SC 13G/A - CADIZ INC (0000727273) (Subject)

    12/6/24 6:52:25 PM ET
    $CDZI
    Water Supply
    Utilities

    Amendment: SEC Form SC 13G/A filed by Wolfspeed Inc.

    SC 13G/A - WOLFSPEED, INC. (0000895419) (Subject)

    12/6/24 11:56:48 AM ET
    $WOLF
    Semiconductors
    Technology